Indium (111In) capromab pendetide (trade name Prostascint) is used to image the extent of prostate cancer.

Following an intravenous injection of Prostascint, imaging is performed using single-photon emission computed tomography (SPECT).

[1] Early trials with yttrium (90Y) capromab pendetide were also conducted.

You can help Wikipedia by expanding it.This antineoplastic or immunomodulatory drug article is a stub.

You can help Wikipedia by expanding it.This nuclear medicine article is a stub.